Evaluation of Anti-SARS-CoV-2 IgG Responses in a Clinical Study of a Biosimilar Candidate to Denosumab Using Singlicate Analysis

Evaluation of Anti-SARS-CoV-2 IgG Responses in a Clinical Study of a Biosimilar Candidate to Denosumab Using Singlicate Analysis

Abstract Background and Objectives During the coronavirus disease-2019 (COVID-19) pandemic there was the uncertainty that the long-term immune response generated upon natural infection or triggered by available severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) vaccines could impact the cl...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandra Ribes, Natalia Krivtsova, Celine Schelcher, Ana Villalba-Izquierdo, Falko Reiss, Mandy Richter, Katrin Reisinger, Johann Poetzl
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-05-01
Series:Drugs in R&D
Online Access:https://doi.org/10.1007/s40268-025-00510-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items